Alexion Pharmaceuticals Inc

Overview

Alexion Pharmaceuticals Inc (Alexion) discovers, develops, and markets therapies based on complement biology and inhibition for rare diseases. Deep understanding of rare disease enables the company to innovate and enter new areas, where there is a great unmet medical need. The company’s portfolio spans complement inhibitors for the treatment of patients with anti-acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG), atypical hemolytic uremic syndrome (aHUS), paroxysmal nocturnal hemoglobinuria (PNH), and neuromyelitis optica spectrum disorder (NMOSD) in anti-aquaporin-4 (AQP4) antibody positive patients. The company also offers novel enzyme replacement therapies for patients with lysosomal acid lipase deficiency (LAL-D), hypophosphatasia (HPP), and ultra-rare metabolic disorders. Alexion is headquartered in New Haven, Connecticut, the US.
Key Stats
Address
121 Seaport Blvd, BOSTON, Massachusetts
Headquarters

United States of America

Contact

1 475 2302596

Website
alexion.com
No of Employees

3,837

Industry

Pharmaceuticals and Healthcare

Peer Comparison

Key Parameters Alexion Pharmaceuticals IncF. Hoffmann-La Roche LtdNovartis AGAmgen Inc
Key Information
Headquarters United States of America Switzerland Switzerland United States of America
Headquarter City BOSTON BASEL BASEL THOUSAND OAKS
Headquarter State/Province Massachusetts - - California
No. of Employees 3,837 101,465 109,000 24,300
Entity Type Private Public Public Public

Products & Services

Alexion is a biopharmaceutical company that conducts research to advance and commercialize complement inhibitors for the treatment of rare and life-threatening metabolic diseases. Major products of the company include the following:

Products
  • Ultomiris
  • Soliris (eculizumab):
  • Strensiq (asfotase alfa) - Hypophosphatasia (HPP)
  • Vitae Eget Libero
  • Vitae Eget Libero

Employees

Name Position Board Since Age Biography
Becky Lillie Senior Vice President; Chief Human Experience Officer, Interim Senior Management 2020 - Ms. Becky Lillie has been the Interim Chief Human Experience Officer of the company since 2020. Prior to this, she...
Uzair Qadeer Chief Diversity Officer Senior Management 2020 - Mr. Uzair Qadeer has been the Chief Diversity Officer of the company since 2020. Prior to this role, he served...
Tanisha Carino, Ph.D. Executive Vice President; Chief Corporate Affairs Officer Senior Management 2019 46 Ms. Tanisha Carino has been the Executive Vice President and Chief Corporate Affairs Officer since 2019. Prior to this, she...
Aradhana Sarin, M.D. Chief Financial Officer; Executive Vice President Senior Management 2019 46 Ms. Aradhana Sarin has been the Chief Financial Officer and Executive Vice President of the company since 2019. Prior to...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Ownership Changes In July, the company was acquired by AstraZeneca Plc, a pharmaceutical company.
2021 Regulatory Approval In April, the company secured approval from US Federal Trade Commission to be acquired by…
2021 Regulatory Approval In July, the company secured approval from European Commission to be acquired by AstraZeneca Plc…
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Achillion Pharmaceuticals Inc

Address

300 George St, New Haven
United States of America

Telephone

1 203 6247000

Website

www.achillion.com
Portola Pharmaceuticals Inc

Address

270 East Grand Avenue, South San Francisco
United States of America

Telephone

1 650 2446864

Website

www.portola.com
Alexion Pharma Mexico S de RL de CV

Address

Paseo de los Tamarindos 90, Torre 1 Piso 6, Oficina A, Mexico City
Mexico

Telephone

52 55 50471500

Website

alexion.com
Alexion Pharma Canada Corp

Address

400 Applewood Crescent, Suite 120, Vaughan
Canada

Telephone

1 866 3931188

Website

alexion.com
Alexion Pharma Germany GmbH

Address

Landsberger Strasse 300, Munchen
Germany

Telephone

49 89 457091300

Website

alexion.com/SelectCountry/Germany.aspx
Alexion Pharma France SAS

Address

103-105 rue Anatole France, Levallois-Perret, Paris
France

Telephone

33 1 47323621

Website

www.alexionpharma.fr
Wilson Therapeutics AB

Address

Kungsgatan 3, STOCKHOLM
Sweden

Telephone

46 8 7960000

Website

www.wilsontherapeutics.com/
Alexion Pharma UK Ltd

Address

3 Furzeground Way, Stockley Park, Uxbridge
United Kingdom

Telephone

44 800 1300212

Website

www.alexion.com

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
22 Feb 2021 Arcturus Therapeutics Acquires License to Nucleic Acid Purification Technologies from Alexion Pharma Licensing Agreement Arcturus Therapeutics Holdings Inc Alexion Pharmaceuticals Inc
12 Dec 2020 AstraZeneca Acquires Alexion Pharma Acquisition AstraZeneca Plc Alexion Pharmaceuticals Inc
19 Nov 2020 Alexion Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with Syneos Health Inc for ALXN-1820 (GDCT0405206) Contract Service Agreement Alexion Pharmaceuticals Inc Syneos Health Inc
06 Nov 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
26 Aug 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
17 Jul 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

177

Active Jobs

74

Posted

75

Closed

Job Trends

Latest Jobs

Job title Company Country
Associate Scientist IV, Injectable Drug Product Development Alexion Pharmaceuticals Inc United States
Senior Director, Hematology-Nephrology Patient Services Alexion Pharmaceuticals Inc United States
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar